|
2006 Journal Article Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipientsDansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2006). Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. Journal of Clinical Pharmacy And Therapeutics, 31 (1), 17-25. doi: 10.1111/j.1365-2710.2006.00697.x |
|
2006 Conference Publication National quality improvement initiatives - CAPTION and beyondWai, A., Horn, F., Mackson, J. M., Maxwell, D. J., Kaye, K. I., McIntosh, K. A., Robertson, M. B., Stanton, L. A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L. K., Tett, S. E., Coombes, J., Petrie, A. and Weekes, L. (2006). National quality improvement initiatives - CAPTION and beyond. 4th Australasian Conference on Safety and Quality in Health Care, Melbourne, Australia, 21st - 23rd August, 2006. |
|
2006 Conference Publication Community-acquired pneumonia: Towards improving outcomes nationally. A national quality improvement initiative 'Down Under'Maxwell, D., Kaye, K. I., McIntosh, K., Robertson, M. B., Stanton, L .A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L., Tett, S. E., Coombes, J., Petrie, A. F., Wai, A., Horn, F., Mackson, J. and Weekes, L. M. (2006). Community-acquired pneumonia: Towards improving outcomes nationally. A national quality improvement initiative 'Down Under'. The 23rd International Conference of the International Society for Quality in Health Care, London / QE11 Centre, 22-25 October 2006. UK: ISQua. |
|
2006 Conference Publication Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxibBarozzi, N. and Tett, S. E. (2006). Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib. The National Institute of Clinical Studies Using Evidence: Using, Melbourne, 19-20 October 2006. Melbourne: National Institute of Clinical Studies. |
|
2006 Conference Publication Spin-offs and bonanzas from Queensland participating in CAPTIONPulver, L., Coombes, J., Petrie, A. F. and Tett, S. E. (2006). Spin-offs and bonanzas from Queensland participating in CAPTION. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited. |
|
2006 Conference Publication Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION projectMaxwell, D. J., Kaye, K. I., MacIntosh, K. A., Robertson, M. B., Stanton, L. A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L., Tett, S. E., Wai, A. and Mackson, J. (2006). Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION project. Australian Society for Antimicrobials 7th Annual Scientific Meeting, Sydney / Crowne Plaza, Coogee Beach, 23-25 February 2006. Sydney: Australian Society for Antimicrobials. |
|
2005 Journal Article Consumer involvement in quality use of medicines (QUM) projects - lessons from AustraliaKirkpatrick, Carl M. J., Roughead, Elizabeth E., Monteith, Gregory R. and Tett, Susan E. (2005). Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia. BMC Health Services Research, 5 (1) 75, 75.1-75.7. doi: 10.1186/1472-6963-5-75 |
|
2005 Journal Article Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationStaatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4 |
|
2005 Journal Article Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, AustraliaCooke, C., Nissen, L. M., Sketris, I. S. and Tett, S. E. (2005). Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia. Clinical Therapeutics, 27 (4), 497-508. doi: 10.1016/j.clinthera.2005.04.009 |
|
2005 Journal Article Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitorsBehan, K., Cutts, C. and Tett, S. E. (2005). Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors. Journal of Clinical Pharmacy And Therapeutics, 30 (4), 337-343. doi: 10.1111/j.1365-2710.2005.00648.x |
|
2005 Conference Publication Population pharmacokinetics: A way forward for optimal dosage prediction in childrenTett, S. E. (2005). Population pharmacokinetics: A way forward for optimal dosage prediction in children. 10th International Congress of Pediatric Laboratory Medicine, Singapore, 3-6 Sept. 2005. Singapore: IAPLM. |
|
2005 Journal Article Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural AustraliaCutts, C. and Tett, S.E. (2005). Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Australian Journal of Rural Health, 13 (1), 43-50. doi: 10.1111/j.1440-1854.2004.00644.x |
|
2005 Conference Publication Cystatin C to estimate renal function: A meta-analysisRoos, J. F., Doust, J., Tett, S.E. and Kirkpatrick, C. M. J. (2005). Cystatin C to estimate renal function: A meta-analysis. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Journal Article Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitorsBehan, K., Cutts, C. and Tett, S. E. (2005). Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors. European Journal of Clinical Pharmacology, 61 (1), 55-58. doi: 10.1007/s00228-004-0865-6 |
|
2005 Journal Article Pharmacokinetic considerations relating to tacrolimus dosing in the elderlyStaatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001 |
|
2005 Conference Publication Consumers on the map: Australia's QUM mapTett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia. |
|
2005 Conference Publication How much, how often, how long?Tett, S. E. (2005). How much, how often, how long?. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Conference Publication Drug utilisation review across jurisdictions: A reality or still a distant dream?Pulver, L. and Tett, S.E. (2005). Drug utilisation review across jurisdictions: A reality or still a distant dream?. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia. |
|
2005 Journal Article Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C., Duffull, S. B., Morris, R. G. and Tett, S. E. (2005). Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. British Journal of Clinical Pharmacology, 60 (5), 560-565. doi: 10.1111/j.1365-2125.2005.02473.x |
|
2005 Journal Article Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritisChan, V., Charles, B. G. and Tett, S. E. (2005). Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. British Journal of Clinical Pharmacology, 60 (3), 257-264. doi: 10.1111/j.1365-2125.2005.02415.x |
